FDA Approved: PLERIXAFOR — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Plerixafor by Meitheal Pharmaceuticals, granting approval for an additional submission related to the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Plerixafor (Plerixafor)

Snippet

SUPPL AP for PLERIXAFOR (PLERIXAFOR)